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Objectives: To assess life-threatening complications among women admitted with severe
hypertensive disorders of pregnancy and compare applicability of World Health Organization
(WHO) maternal near-miss (MNM) criteria and the recently adapted sub-Saharan African
(SSA) MNM criteria in eastern Ethiopia.
Methods: Of 1,054 women admitted with potentially life-threatening conditions between
January 2016 and April 2017, 562 (53.3%) had severe preeclampsia/eclampsia. We applied
the definition of MNM according to the WHO MNM criteria and the SSA MNM criteria.
Logistic regression was performed to identify factors associated with severe maternal out-
comes (MNMs and maternal deaths).
Results: The SSA MNM criteria identified 285 cases of severe maternal outcomes: 271
MNMs and 14 maternal deaths (mortality index 4.9%). The WHO criteria identified 50 cases
of severe maternal outcomes: 36 MNMs and 14 maternal deaths (mortality index 28%).
The MNM ratio was 36.6 per 1,000 livebirths according to the SSA MNM criteria and 4.9
according to the WHO criteria. More than 80% of women in both groups had MNM events
on arrival or within 12 hours after admission. Women without antenatal care, from rural
areas, referred from other facilities, and with concomitant hemorrhage more often developed
severe maternal outcomes.
Conclusion: Regarding hypertensive disorders of pregnancy, the SSA tool is more inclusive
than the WHO tool, while still maintaining a considerably high mortality index indicat-
ing severity of included cases. This may enable more robust audits. Strengthening the referral
system and improving prevention and management of obstetric hemorrhage in women with
hypertensive disorders of pregnancy are required to avert severe maternal outcomes.
Keywords: severe maternal outcomes, hypertensive disorders of pregnancy, maternal near-
miss, maternal mortality, sub-Saharan Africa
Introduction
Hypertensive disorders of pregnancy (HDPs) remain one of the leading causes of
maternal mortality and severe morbidity.1–5 According to the World Health
Organization (WHO), 14% of global maternal deaths (MDs) in 2014 could be attrib-
uted to HDPs.6 In sub-Saharan Africa (SSA), HDPs are the second-leading cause of
MDs and complications.6,7 In general, the incidence of preeclampsia/eclampsia
is higher in Africa than any other region.8 A recent systematic review in Ethiopia
showed a combined prevalence of preeclampsia/eclampsia of 5.5%, with a wide gap
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from 1.2% in a national study to 18.3% in a study conducted
in public health institutions in southern Ethiopia.9 In the 2018
Ethiopian Maternal Death Surveillance and Response
System report, 16% of MDs were due to HDPs.10
In the maternal health continuum, pregnancy may be
uncomplicated or complicated by mild morbidity, potentially
life-threatening conditions, life-threatening complications, or
death.11 By applying this continuum to HDPs, preeclampsia
may be classified as mild morbidity or severe preeclampsia
and eclampsia as severe morbidity or potentially a life-
threatening condition, and maternal near-misses (MNMs)
from preeclampsia/eclampsia as life-threatening complica-
tions preceding MD. Each course can be viewed from this
perspective as a progressive chain of events leading to increas-
ingly severe morbidity and ultimately to MD. Understanding
the burden at each segment of the continuum and identifying
factors affecting the progression from mild morbidity to life-
threatening complications (includingmortality) is essential for
designing appropriate interventions.12 To facilitate such stu-
dies, the WHO proposed MNM criteria, which had been
previously found to be less applicable in low-income
settings.13,14 Using a Delphi consensus approach, a panel of
experts thus proposed an adaptation of these criteria: the SSA
MNM criteria for use in low-income settings.15
Factors associated with severe maternal outcomes in
HDPs have not been studied in Ethiopia. The objective of
this study was to assess the occurrence of MNMs and
MDs according to the WHO MNM criteria and its recent
adaptation for SSA countries among women admitted with
severe preeclampsia and eclampsia in a university and
a regional hospital in eastern Ethiopia.
Methods
This study was a sub-analysis of a prospective study con-
ducted on severe maternal morbidity in Hiwot Fana
Specialized University Hospital and Jugel Hospital in
Harar, eastern Ethiopia.16 Hiwot Fana is a tertiary-hospital
affiliated with the College of Health andMedical Sciences of
Haramaya University, where approximately 3,500 births take
place annually. Jugel Hospital is a regional public hospital
found in the same city, where approximately 2,000 births
take place annually. Between January 2016 and April 2017,
all cases of potentially life-threatening conditions (severe
postpartum hemorrhage, severe preeclampsia, eclampsia,
ruptured uterus, sepsis/severe systemic infection, severe
complications of abortion) were prospectively identified on
a daily basis and followed until discharge.16 During this
period,1,054 women with potentially life-threatening
conditions were admitted to both hospitals, of whom 562
were related to HDPs. A total of 7,929 deliveries resulting in
7,404 live births were registered in both hospitals during the
same period (Figure 1).
We applied the definition of MNM according to the
adapted SSA15 and WHO MNM criteria17 to women with
severe preeclampsia and eclampsia. For each woman, we
retrospectively evaluated the presence of MNM indicators
according to the SSA and WHO criteria. SSA MNM
criteria were developed for use in low-resource settings,
where some of the WHO criteria that focus on organ
dysfunction are difficult to apply. SSA MNM criteria
include 27 MNM indicators (including 19 from the 25-
indicator WHO MNM tool). The most important modifica-
tion was lowering the threshold for number of units of
blood for transfusion in major obstetric hemorrhage from
five (in the original WHO MNM criteria) to two units and
adding eclampsia, a clinical criterion, to the adapted tool.15
The comparison of the SSA and WHO MNM criteria with
their respective definitions is shown in Table S1.
For all eligible women, data were collected prospec-
tively on sociodemographic characteristics, obstetric condi-
tions and complications, and maternal and perinatal
outcomes at discharge. For the current study, we used informa-
tion related to women having severe preeclampsia and
eclampsia only. Case definitions for HDPs were: preeclampsia
(new onset of hypertension with proteinuria after 20 weeks of
gestation); severe preeclampsia (severe hypertension >160/
110 mmHg) plus one of severe headache, blurring of vision,
epigastric pain, creatinine >1.1, HELLP (hemolysis, elevated
liver enzymes [>2×], lowplatelet count [<100,000]) syndrome,
or pulmonary edema; and preeclampsia with seizure(s) with-
out history of epilepsy, including coma in preeclampsia.18
Data were collected from medical records after discharge.
Trained nurse midwives collected the data under the super-
vision of the first author (AKT) and other senior researchers
from the College of Health and Medical Sciences, Haramaya
University.
Data Processing and Analysis
Data were entered using EpiData v3.1 (www.epidata.dk),
and SPSS 23 (IBM, Armonk, NY, USA) was used for
analysis. Descriptive statistics using frequencies and per-
centages were used to describe characteristics of partici-
pants. Presence of severe maternal outcomes (MNMs and
MDs) according to SSA or WHO MNM criteria was the
dependent variable. MNM indicators, such as MNM ratio,
mortality index, and severe maternal outcome ratio, were
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calculated and compared between the two classifications.
The MNM ratio is the number of MNMs per 1,000 live
births. The severe maternal outcome ratio is the of MNM
ratio and MDs per 1,000 live births. The mortality index is
the proportion of MDs from all women with severe mater-
nal outcomes (MDs/[MNM + MDs]). Possible risk factors
for developing severe maternal outcomes were first
assessed using binary logistic regression. A multivariate
model was then built, retaining variables for logistic
regression if p≤0.25 in the binary model in either
the SSA or WHO group. Level of statistical significance
for the model was set at p<0.05.
Ethical Considerations
This study was conducted in accordance with the Declaration
of Helsinki. The study protocol was reviewed and approved
by the Institutional Health Research Ethics Review
Committee of the College of Health and Medical Sciences,
Haramaya University (C/A/R/D/01/1681/16) in Ethiopia.
Data were collected after discharge of the women, and thus
did not affect the course or outcome of treatment. Informed
consent was not sought, since data were collected from
medical records. No identifying information was collected.
Results
Of 562 women with potentially life-threatening conditions
related to severe preeclampsia and eclampsia, the WHO
MNM criteria identified 50 severe maternal outcomes
(8.9%): 36 MNMs and 14 MDs, while SSA MNM criteria
identified 285 (50.7%): 271 MNMs and 14 MDs. The mean
age of women in the WHO group, SSA group, and
MDs were 25.0, 23.8, and 24.4 years, respectively.
Figure 1 Flowchart of severe HDPs in eastern Ethiopia: comparing the original WHO and adapted sub-Saharan African MNM criteria.
Abbreviations: HDPs, hypertensive disorders of pregnancy; WHO, World Health Organization; MNM, maternal near miss; MDs, maternal death.
Dovepress Tura et al
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No antenatal care, preterm births, and multiparity were
commoner among the WHO group and MDs compared to
the SSA group. No other significant differences were
observed among the three groups (Table 1).
Severe preeclampsia and eclampsia complicated 337
(4.3%) and 225 (2.8%) of all births during the study period
(n=7,929). All women with eclampsia and 60with severe
preeclampsia (17.8%) fulfilled the SSA MNM criteria,
while only 25with eclampsia (11.6%) and 24 with severe
preeclampsia (7.1%) fulfilled the WHO MNM criteria.
The severe preeclampsia/eclampsia–related MNM ratio
was 4.9 per 1,000 live births according to WHO MNM
criteria and 36.6 according to SSA criteria. Details of
severe preeclampsia/eclampsia–related complications and
MNM indicators stratified by WHO or SSA MNM criteria
are summarized in Table 2. Hemorrhage was diagnosed in
eleven (22%) women in the WHO group and 27 (9.5%) in
the SSA group. Blood products were administered to 38
(13.3%) women, of whom only eleven (3.9%) received
five or more units (Table 3).
Concerning the distribution of MNM events in the two
groups, respiratory dysfunction (n=23) followed by coagula-
tion dysfunction (n=16) were commonest in theWHO group.
In the SSA group, eclampsia (n=225) followed by coagula-
tion dysfunction (n=34) were the most prevalent. Of 225
women with eclampsia, only 26 (11.6%) fulfilled the WHO
MNM criteria. The remaining (n=199; 88.4%) did not fulfill
WHO MNM criteria, because organ dysfunction was not
mentioned in their files. The mortality index was 28% for
the WHO group and 4.9% in the SSA group. For all MNM
events, unsurprisingly mortality indices were equal or higher
in the WHO group compared to the SSA group (Table 4).
More than 80% of women in both groups had
MNMs already on arrival or within 12 hours after admission.
A majority of those with MNMs on arrival were referred
from other facilities: 28 (68.3%) in the WHO group and 163
(64.9%) in SSA group. The mortality index was higher
among women presenting to hospitals with
MNMs compared to MNMs occurring in hospital after
admission (Table 5). In women fulfilling SSAMNM criteria,
severe maternal outcomes were higher in those who were
referred (adjusted OR 1.97, 95% CI 1.13–3.41), had not
received antenatal care (adjusted OR 3.13, 95% CI 1.77–-
5.54), and rural residents (adjusted OR 2.32, 95% CI 1.11–-
4.87). In theWHO group, women with concomitant obstetric
hemorrhage (adjusted OR 3.75, 95% CI 1.10–12.76), who
were referred (adjusted OR 3.34, 95% CI 1.20–9.31), and
with no antenatal care (adjusted OR 3.17, 95% CI 1.03–9.76)
were at increased risk of developing severe maternal out-
comes. No statistically significant association was observed
between severe maternal outcomes and age, gestational age,
number of pregnancies, or mode of delivery in either group
(Table 6).
Discussion
The MNM ratio among women with severe HDPs in east-
ern Ethiopia was 4.9 per 1,000 live births according to
WHO MNM criteria and 36.6 according to the adapted










23.8 (±5.5) 25.0 (±5.6) 24.4 (±4.8)
<20 53 (18.6) 6 (12.0) 2 (14.3) 0.770
20–34 207 (72.6) 38 (76.0) 11 (78.6)
≥35 25 (8.8) 6 (12.0) 1 (7.1)
Referred
Yes 184 (64.8) 35 (70.0) 13 (92.9) 0.081
No 100 (35.2) 15 (30.0) 1 (7.1)
Booked for ANC
Yes 94 (33.0) 9 (18.0) 2 (14.3) 0.043
No 191 (67.0) 41 (82.0) 12 (85.7)
Gestational age
(weeks)
<28 10 (5.5) 2 (5.7) 1 (12.5) 0.049
28–36 103 (56.6) 28 (80.0) 6 (75.0)
≥37 69 (37.9) 5 (14.3) 1 (12.5)
Gravida
1 138 (48.6) 17 (34.0) 6 (42.8) 0.030
2–4 91 (32.0) 13 (26.0) 4 (28.6)
>4 55 (19.4) 20 (40.0) 4 (28.6)
Number of
children
0 111 (38.9) 14 (28.0) 3 (21.4) 0.060
1–4 128 (44.9) 20 (40.0) 7 (50.0)
≥5 46 (16.2) 16 (32.0) 4 (28.6)
Mode of delivery
Vaginal 193 (67.7) 33 (70.2) 9 (64.3) 0.903
Cesarean
section
92 (32.3) 14 (29.8) 5 (35.7)
Admission date
Working day 200 (70.2) 38 (76.0) 9 (64.3) 0.608
Not a
working day
85 (29.8) 12 (24.0) 5 (35.7)
Notes: Bold values: respective Chi Square (X2) values for the significant ones are as
follows: forANC:X2 cal =6.2705;Gestational age:X2 cal=9.5597;Gravida:X2 cal=10.7168.
Abbreviations: ANC, antenatal care; SSA, sub-Saharan Africa; WHO, World
Health Organization, MDs, maternal deaths.
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SSA MNM criteria. Using the adapted SSA MNM criteria,
we were able to identify robustly that severe maternal
outcomes were higher among women who did not have
any antenatal care, were referred from other facilities, and
were rural residents. Increased risk of severe maternal
outcomes among women with concomitant obstetric
hemorrhage were observed among cases fulfilling WHO
MNM criteria only, indicating the severity of these cases.
The contribution of severe HDPs among women with
potentially life-threatening conditions (53.3%) was com-
parable with other studies in Ethiopia19,20 and Nigeria.21
Severe maternal outcomes related to severe preeclampsia/
eclampsia according to WHO criteria (6.8 per 1,000 live
births) was lower than a finding from Uganda (8.6) and
much lower than that of Nigeria (24.0).5,22 It was higher,
however, than in a study from Brazil (4.2).23 This may be
related to differences in study setting and health-care sys-
tems. Our study was institution-based in a low institutional
delivery (26%) setting where most women with minor
complications may not come to the hospital, where mainly
high-risk women come.24
The risk of maternal mortality is higher among women
with organ dysfunction (fulfilling the WHO MNM cri-
teria) and highest among those with uterine dysfunction
(60%), followed by cardiovascular (50%) and coagulation
dysfunction (50%). Although low in absolute number (n=4),
mortality was highest (75%) among women who underwent
laparotomy in the SSA group. Overall, the mortality index
was 4.9% and 28% among cases in the SSA and WHO
groups, respectively. The mortality index for WHO
MNMs wass lower than in the study from Nigeria
(49.2%),23 but higher than in the study from Uganda (8.3).5
Manywomenwith severe maternal outcomes already have
organ dysfunction on arrival, which makes treatment in hos-
pitals too late to save the life of the woman or prevent organ
failure. This advanced stage of illness on admission may be
attributed to the low institutional delivery rate and a poorly
functioning referral system.24,25 Community-level interven-
tions are required for meaningful reductions in maternal mor-
tality due to HDPs.25,26 Health workers in the community and
lower district hospitals—whowere capable of identifying and
initiating treatment, but lack refresher training — should be
refreshed on signs and symptoms, timely referral, and prophy-
lactic use of magnesium sulfate.27–29 They should also be
vigilant about the risk of obstetric hemorrhage, since this
Table 2 Distribution of HDP-related Complications and MNM Indicators in Eastern Ethiopia
All HDPs, n (%) All SMOs MNMs MNM Ratio MMR SMO Ratio MNM:MDs MI CFR
SSA WHO SSA WHO SSA WHO SSA WHO SSA WHO SSA WHO
SPE 337(60) 60 24 55 19 7.4 2.6 67.5 8.1 3.2 11 3.8 8.3 20.8 1.5
Eclampsia 225(40) 225 26 216 17 29.2 2.3 121.6 30.4 3.5 24 1.9 4.0 34.6 4.0
Total 562(100) 285 50 271 36 36.6 4.9 189.1 38.5 6.8 19.4 3.6 4.9 28.0 2.5
Abbreviations: S-PE, severe preeclampsia; SSA, sub-Saharan Africa; WHO,World Health Organization; HDPs, hypertensive disorders of pregnancy; MNMs, maternal near-miss
es; MMR, maternal mortality ratio; SMOs, severe maternal outcomes (MNMs + MDs); MDs, maternal deaths; MI, mortality index (MDs/SMOs × 100); CFR, casefatality rate.
Table 3 Distribution of Underlying and Contributing Factors of








Severe preeclampsia 60 (21.1) 24 (48.0)
Eclampsia 225 (78.9) 26 (52.0)
Obstetric hemorrhage* 27 (9.5) 11 (22.0)
Abortion-relateda 2 (0.7) 0
Abruptio placenta 5 (1.8) 2 (4.0)
Placenta previa 2 (0.7) 0
Uterine rupture 3 (1.1) 2 (4.0)
Postpartum hemorrhage 10 (3.5) 6 (12.0)
Other 5 (1.8) 1 (2.0)
Sepsis or severe systemic
infection*
19 (6.7) 8 (16.0)
Contributing factors
Anemia (<7g/dl) 31 (10.9) 8 (16.0)
Previous cesarean section 9 (3.2) 2 (4.0)
Critical interventions or ICU
admission
141 (49.5) 37 (74)
Use of blood products 38 (13.3) 11 (22.0)
Admission to ICU 40 (14.0) 23 (46.0)
Cesarean section 87 (30.5) 13 (26.0)
Laparotomy 4 (1.4) 4 (8.0)
Notes: *In women with HDPs; adefinition of abortion in Ethiopia (<28 weeks).
Abbreviation: ICU, intensive care unit.
Dovepress Tura et al
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appears to be a predilecting factor for severematernal outcome
among women with HDPs.30
Despite the reported high use of magnesium sulfate for
prophylaxis (95.8%) or treatment (96.4%), lack of adequate
intensive care units and late arrival of women results in a high
mortality index. This highlights the need to assess quality of
care or timeliness of prophylaxis or treatment. Further
audits of appropriateness of management and opportunities
for improvement (including prereferral management) are
required to improve quality of obstetric care and avert pre-
ventable maternal mortality.31,32
Strengths of this study were the use of a prospective
design in case selection and use of diagnosis made by the
treating clinician. This study also had some limitations.
First, although treatment with magnesium sulfate was
assessed, data on its timing were not collected, and we
are unable to comment about any delays. Second, we feel
that incompleteness of medical records may affect our
understanding about timing of prophylactic use of
magnesium sulfate among women with eclampsia. We
also feel that the existing low institutional delivery rate
(26%) may result in underestimation of the denominator
(live births),24 since the majority of hospital births are
among high-risk referred cases.33 Therefore, findings
from this study may not reflect a population-based esti-
mate of the condition.
In this low-resource setting, we feel that for audit purposes,
the adapted SSAMNM tool should be used instead of the strict
WHO tool, as the mortality index is still 4.9%, indicating
the severity of cases.15,34,35 Many lessons to be learned will
be missed by lookingonly at the cases identified by the WHO
MNM tool. One of the major aims of treatment is to prevent
organ dysfunction in women with complications and thus
focus on organ dysfunction, as identification criteria will not
address this major task. Improvement of case detection in the
Table 4 Distribution of MNM Events in Women with HDPs in Eastern Ethiopia
Sub-Saharan Africa World Health Organization
MNMs, n (%) MDs, n (%) MI (%) MNMs, n (%) MDs n (%) MI (%)
Cardiovascular dysfunction 7 (2.6) 7 (50.0) 50.0 7 (19.4) 7 (50.0) 50.0
Respiratory dysfunction 15 (5.5) 8 (57.1) 34.8 15 (41.7) 8 (57.1) 34.8
Uterine dysfunction 2 (0.7) 3 (21.4) 60.0 2 (5.6) 3 (21.4) 60.0
Coagulation dysfunction 26 (9.6) 8 (57.1) 23.5 8 (22.2) 8 (57.1) 50.0
Renal dysfunction 1 (0.4) 1 (7.1) 50.0 1 (2.8) 1 (7.1) 50.0
Hepatic dysfunction 5 (1.8) 1 (7.1) 16.7 5 (13.9) 1 (7.1) 16.7
Neurologic dysfunction 7 (2.6) 6 (42.9) 46.2 7 (19.4) 6 (42.9) 46.2
Eclampsia 216 (79.4) 9 (64.3) 4.0 17 (47.2) 9 (64.3) 34.6
Severe preeclampsia with ICU admission 14 (5.2) 4 (28.6) 22.2 5 (13.9) 4 (28.6) 44.4
Sepsis or severe systemic infections 16 (5.9) 3 (21.4) 15.8 5 (13.9) 3 (21.4) 37.5
Pulmonary edema 6 (2.2) 2 (14.3) 25.0 4 (11.1) 2 (14.3) 33.3
Total 271 (100) 14 (100) 4.9 36 (100) 14 (100) 28.0
Abbreviations: ICU, intensive care unit; MNMs, maternal near-misses; MDs, maternal deaths; MI, mortality index (MDs/MNM + MDs).




1. All live births in the population under
surveillance
7404 7404
2. SMOs (n) 285 50
MDs (n) 14 14
MNMs (n) 271 36
3. Overall near-miss indicators
SMO ratio (per 1,000 live births) 38.5 6.8
MNM ratio (per 1,000 live births) 36.6 4.9
MNM-mortality ratio (MNMs:MDs) 19.4 2.6
Mortality index (%) 4.9 28
4. Hospital-access indicators
SMO cases presenting the organ dysfunction or maternal
death within 12 hours of hospital stay (SMO12; n)
251 41
Proportion of SMO12 cases among all SMO cases 88.1 82.0
Proportion of SMO12 cases coming from other health
facilities
64.9 68.3
SMO12 rate (per 1,000 live births) 33.9 5.5
SMO12 mortality index (%) 4.8 29.3
5. Intrahospital care
Intrahospital SMOs (n) 34 9
Intrahospital SMO rate (per 1,000 live births) 4.6 1.2
Intrahospital mortality index (%) 5.9 22.2
Abbreviations: SMO, severe maternal outcome; SSA, sub-Saharan Africa; WHO,
World Health Organization; MNM, maternal near-miss; MDs, maternal deaths.
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SSA tool was achieved by two notable changes: lowering the
threshold of blood transfusion to at least two units and includ-
ing eclampsia in MNM criteria.15 Lack of adequate blood for
transfusion and limited resources for investigation could be the
major reasons for (inevitable) underreporting of MNMs using
theWHO criteria. In addition, in most hospitals in low-income
settings, it is unlikely for a woman to receive five ormore units
of blood, due to restricted availability.36 Limited infrastructure
for diagnosis or management and lack of specialists in inten-
sive care make the use of the WHO criteria impractical in
many low-resource settings.
In conclusion, the adapted SSA MNM tool identifies
a larger number of cases amenable to audit than the WHO
MNM tool, which may help in preventing organ dysfunction.
The SSAMNM tool should be used for averting severe mater-
nal outcomes related to HDPs, as reverting cases fulfilling the
WHO MNM criteria is difficult because of organ dysfunction
or failure.15,17 The majority of women with severe maternal
outcomes reached hospitals in a critical condition, and thus an
important key to improve outcomes of HDPs seems to be at
lower-level facilities and in strengthening the referral system.
Quality of care forwomenwith severeHDPs should be audited
to identify areas of improvement and prevent organ dysfunc-
tion and MDs.
Disclosure
The authors report no conflicts of interest in this work.
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